SCHEMBL6998732

SCHEMBL6998732

CC(=O)C(O)(C(=O)Cl)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
KMT2A Q03164 2/20 0.41
MAPT P10636 1/20 0.41
KCNN4 O15554 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
CYP2D6 P10635 1/20 0.37
CES1 P23141 2/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10569602 1.00 CYP1A2 (0.43) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL378835 0.83 CYP1A2 (0.46) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL2371928 0.83 CYP1A2 (0.46) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL2372942 0.83 CYP1A2 (0.46) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL9587221 0.80 MAPT (0.42) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL9586541 0.80 MAPT (0.42) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL9484935 0.78 ALDH1A1 (0.42) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL7782499 0.78 CES1 (0.52) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL11502589 0.76 CYP1A2 (0.41) CYP1A2KMT2AMAPTKCNN4CYP2C19
SCHEMBL12083438 0.76 KCNN4 (0.60) KMT2AMAPTKCNN4HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973774-B1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2003-01-22 EP disclosed
EP-0579615-B1 NEW BI- AND TRICYCLIC AMINOALCOHOL ESTERS, THEIR PREPARATION AND THEIR USE IN MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2001-07-04 EP disclosed
EP-0973774-A1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2000-01-26 EP disclosed
WO-1998040384-A1 1,5-DIHYDRO-PYRAZOLO[3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1998-09-17 WO disclosed
EP-0579615-A1 NEW BI- AND TRICYCLIC AMINOALCOHOL ESTERS, THEIR PREPARATION AND THEIR USE IN MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) 1994-01-26 EP disclosed
WO-1992016528-A1 NEW BI- AND TRICYCLIC AMINOALCOHOL ESTERS, THEIR PREPARATION AND THEIR USE IN MEDICAMENTS BOEHRINGER INGELHEIM KG (DE) 1992-10-01 WO disclosed
US-4952683-A WOUND HEALING AGENTS SOLCO BASEL AG (CH) 1990-08-28 US disclosed
EP-0146810-A2 Process for the preparation of sphingosin derivatives Solco Basel AG (CH) 1985-07-03 EP disclosed
EP-0062887-B1 INDOLINONE-2 DERIVATIVES, PROCESS FOR THEIR PREPARATION AND NEURO-ANABOLIC MEDIUMS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1984-07-11 EP disclosed
EP-0062887-A1 Indolinone-2 derivatives, process for their preparation and neuro-anabolic mediums containing them HOECHST AKTIENGESELLSCHAFT (DE) 1982-10-20 EP disclosed
US-RE30415-E ANTIINFLAMMATORY AGENTS, ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1980-10-07 US disclosed
US-RE30314-E ANTIINFLAMMATORY, ANTITHROMBOTIC ELI LILLY AND COMPANY (US) 1980-06-24 US disclosed
US-4133884-A Substituted pyrroloquinoxalinones and diones used in treating inflammation in warm blooded mammals ELI LILLY AND COMPANY (US) 1979-01-09 US disclosed
US-4087527-A ANTIINFLAMMATORY AND ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1978-05-02 US disclosed
US-4075206-A ANTIINFLAMMATORY, ANTITHROMBOTIC ELI LILLY AND COMPANY (US) 1978-02-21 US disclosed